ProtemixProtemix
Products in Development

PX811019, in Phase 2 trials, is a potential
oral treatment for diabetic heart failure.
Latest News
Protemix raises US$14.5 million in first close of Series A financing More News . . .
Contact Protemix | Site Map |
  Search
built@zoomedia.com
©2009 Protemix Corporation Limited | Privacy Statement | Terms of Use